Drive Innovations is a leading organization focused on developing antiviral drugs to combat RNA virus infections. With strong ties to Emory University and substantial funding, Drive Innovations boasts a world-class infrastructure for drug development. The team is dedicated to identifying novel antiviral therapies and developing effective, broadly active antiviral agents.
Their primary approach involves targeting virally encoded polymerases, particularly RNA directed RNA polymerase (RdRp), using nucleoside/nucleotide analogues as competitive alternative substrate inhibitors. This cutting-edge research aims to provide innovative solutions to the global burden of viral diseases.
